Successful conclusion of EU project Alzheimer’s Detect & Prevent with early validation of two Brain+ DTx technologies and extra funding
Company Announcement Copenhagen, Denmark, February 8, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 · The ‘Alzheimer’s Detect & Prevent’ project, led by Brain+ and funded under the EU Horizon2020 innovation framework, has been approved by the European Commission · The project has funded the development and early clinical feasibility testing of two key Brain+ technologies: 1) the ‘Starry Night’ cognitive test and 2) 1[st] generation